Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

This study has been withdrawn prior to recruitment.

First Received: October 4, 2006 Last Updated: February 9, 2009 History of Changes

Sponsored by:	Copenhagen University Hospital at Herlev
Information provided by:	Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:	NCT00718055

Purpose

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Condition	Phase
Neoplasm Metastasis Liver Colorectal Neoplasms Magnetic Resonance Imaging Contrast Media	Phase IV

MedlinePlus related topics: Cancer Colorectal Cancer MRI Scans

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser

Further study details as provided by Copenhagen University Hospital at Herlev:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	50
Study Start Date:	November 2006

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

consekutive group of liver metastatic patients

Criteria

Inclusion Criteria:

biopsy proved liver metastasis

Exclusion Criteria:

pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00718055

Locations

Denmark
Copenhagen Uni. Hospital at Herlev dept. of Radiology
Herlev, Denmark, 2730

Sponsors and Collaborators

Copenhagen University Hospital at Herlev

Investigators

Principal Investigator:

Vibeke Løgager, M.D.

Copenhagen University Hospital at Herlev

More Information

No publications provided

Responsible Party:	Herlev Hospital ( Vibeke Løgager )
Study ID Numbers:	KA-20060096
Study First Received:	October 4, 2006
Last Updated:	February 9, 2009
ClinicalTrials.gov Identifier:	NCT00718055 History of Changes
Health Authority:	Denmark: Danish Medicines Agency

Keywords provided by Copenhagen University Hospital at Herlev:

MRI
liverspecific
contrast
colorectal
metastases

Study placed in the following topic categories:

Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Neoplasm Metastasis

Gastrointestinal Neoplasms
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:

Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Neoplasms

Neoplastic Processes
Pathologic Processes
Neoplasms by Site
Digestive System Diseases
Neoplasm Metastasis
Gastrointestinal Neoplasms
Colorectal Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009